Thymosin Alpha-1 · For cancer support

Thymosin Alpha-1 for cancer support

On chemo and immune system is wrecked. Thymosin Alpha-1?

A-Tier Immune Strong clinical

New to peptides? Start with the foundations ->

Why people use Thymosin Alpha-1 for cancer support

On chemo and immune system is wrecked. Thymosin Alpha-1? The short answer: yes, this is one of the more-discussed uses for Thymosin Alpha-1 - but the evidence quality and the right protocol depend on what you're actually trying to fix.

This page covers what's known, what's not, and what the editorial take is for normal humans considering Thymosin Alpha-1 for cancer support.

What the evidence says

Evidence tier: Strong clinical. Multiple human studies support the dosing protocol; not yet FDA-labeled for this exact indication but close.

Approved as Zadaxin for chemotherapy support in 35+ countries.
Multiple oncology RCTs show reduced infection rates and faster immune recovery in chemo patients.
Oncology coordination essential - this is not a substitute for cancer treatment.

Protocol notes

1.6mg subQ twice weekly during and after chemotherapy. Oncologist or integrative oncologist supervision.

Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.

How it's dosed (quick version)

Standard protocol is 1.6 milligrams (a small subQ shot) twice a week, for 6 to 12 weeks. The branded version (Zadaxin) is approved abroad for hepatitis and chemo support. In the US, it is compounded off-label for general immune support. Always with a doctor.

Typical starting dose: 1.6 mg subQ (under-the-skin shot) twice weekly. Some clinicians start at 0.8 mg for sensitive patients.
Typical maintenance dose: 1.6 mg twice weekly during a 6-12 week cycle.
Frequency: Twice weekly. Most protocols use a fixed schedule (Monday and Thursday) to make it routine.
Cycle length: 6 to 12 weeks per cycle. Hepatitis protocols can run longer (up to 6 months) under specialist care.

Full dosing breakdown ->

What to skip

Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.

Where to go next

Full Thymosin Alpha-1 directory entry - status, sourcing, studies, what to skip
What are peptides - if you skipped the foundation
How peptides actually work - mechanism in plain English
The Tier List - which ones to take seriously
Subscribe to the dispatch

Subscribe to the dispatch

The weekly Protocol One dispatch covers what's moving in peptides, GLP-1s, and longevity protocols. Free. 5-min read. Broken down for normal humans.

-> Subscribe free

Last reviewed · 2026-05-07 · Page generated by Protocol One matrix engine